Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Great contrary indicator/ time to buy

<< Previous

Bullboard Posts

Next >>

Comment by fox7mfon Mar 24, 2023 11:28am

144 Views

Post# 35358658

RE:Great contrary indicator/ time to buy

It's not surprising that the conversation has dried up here. MC has suggested everything we've been waiting on will come to light at the outset of June. So, does that mean no news other than business as usual at the AGM? Does that mean zero NR's regarding one or two accelerated approvals or priority reviews? How's that possible if MC wants the market cap to reflect what it should ($1b+usd) before a buyout or partnership? How's it possible for the acquiring BP to start two ph3 trials this year if they don't take possession of Onc/Pela soon?

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle